← Back to patent-cliff list
CAS 27673-47-8
2-[(5,8-dihydronaphthalen-1-yloxy)methyl]oxirane
Codes: Nadolol-009
Application context (from source-drug indications)
Diabetic macular oedemaNadololDiabetic retinopathyNadolol感染性角结膜炎NadololDry eye syndromeNadololHypertensionNadololHyperthyroidismNadolol
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Nadolol | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-[(5,8-dihydronaphthalen-1-yloxy)methyl]oxirane→tert-butyl[3-(5,8-dihydronaphthalen-1-yloxy)-2-hydroxypropyl]amine→tert-Butylamine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.